ConductScience.org, home
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
API referenceFor AI assistants

Trial · NCT01442038

Results by group80

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 80

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationRanolazineKM Estimate: 1 Month3.4percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationPlaceboKM Estimate: 1 Month2.3percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationRanolazineKM Estimate: 6 Months11.3percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationPlaceboKM Estimate: 6 Months10.0percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationRanolazineKM Estimate: 12 Months19.1percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationPlaceboKM Estimate: 12 Months17.3percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationRanolazineKM Estimate: 1 Calendar Year20.2percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationPlaceboKM Estimate: 1 Calendar Year18.9percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationRanolazineKM Estimate: 18 Months23.8percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationPlaceboKM Estimate: 18 Months25.3percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationRanolazineKM Estimate: 24 Months27.6percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationPlaceboKM Estimate: 24 Months29.4percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationRanolazineKM Estimate: 2 Calendar Years30.7percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationPlaceboKM Estimate: 2 Calendar Years31.0percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationRanolazineKM Estimate: 30 months31.1percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationPlaceboKM Estimate: 30 months33.8percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationRanolazineKM Estimate: 36 Months32.2percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationPlaceboKM Estimate: 36 Months37.8percentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationRanolazineKM Estimate: 3 Calendar YearsNApercentage of participants
Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without RevascularizationPlaceboKM Estimate: 3 Calendar Years37.8percentage of participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01442038/results

API referenceFor AI assistants